Increased functional connectivity between limbic brain areas in healthy individuals with high versus low sensitivity to cold pain: A resting state fMRI study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
09
01
2022
accepted:
03
04
2022
entrez:
20
4
2022
pubmed:
21
4
2022
medline:
23
4
2022
Statut:
epublish
Résumé
The representation of variability in sensitivity to pain by differences in neural connectivity patterns and its association with psychological factors needs further investigation. This study assessed differences in resting-state functional connectivity (rsFC) and its association to cognitive-affective aspects of pain in two groups of healthy subjects with low versus high sensitivity to pain (LSP vs. HSP). We hypothesized that HSP will show stronger connectivity in brain regions involved in the affective-motivational processing of pain and that this higher connectivity would be related to negative affective and cognitive evaluations of pain. Forty-eight healthy subjects were allocated to two groups according to their tolerability to cold stimulation (cold pressor test, CPT, 1°C). Group LSP (N = 24) reached the cut-off time of 180±0 sec and group HSP tolerated the CPT for an average of 13±4.8 sec. Heat, cold and mechanical evoked pain were measured, as well as pain-catastrophizing (PCS), depression, anxiety and stress (DASS-21). All subjects underwent resting state fMRI. ROI-to-ROI analysis was performed. In comparison to the LSP, the HSP had stronger interhemispheric connectivity of the amygdala (p = 0.01) and between the amygdala and nucleus accumbens (NAc) (p = 0.01). Amygdala connectivity was associated with higher pain catastrophizing in the HSP only (p<0.01). These findings suggest that high sensitivity to pain may be reflected by neural circuits involved in affective and motivational aspects of pain. To what extent this connectivity within limbic brain structures relates to higher alertness and more profound withdrawal behavior to aversive events needs to be further investigated.
Sections du résumé
BACKGROUND
The representation of variability in sensitivity to pain by differences in neural connectivity patterns and its association with psychological factors needs further investigation. This study assessed differences in resting-state functional connectivity (rsFC) and its association to cognitive-affective aspects of pain in two groups of healthy subjects with low versus high sensitivity to pain (LSP vs. HSP). We hypothesized that HSP will show stronger connectivity in brain regions involved in the affective-motivational processing of pain and that this higher connectivity would be related to negative affective and cognitive evaluations of pain.
METHODS
Forty-eight healthy subjects were allocated to two groups according to their tolerability to cold stimulation (cold pressor test, CPT, 1°C). Group LSP (N = 24) reached the cut-off time of 180±0 sec and group HSP tolerated the CPT for an average of 13±4.8 sec. Heat, cold and mechanical evoked pain were measured, as well as pain-catastrophizing (PCS), depression, anxiety and stress (DASS-21). All subjects underwent resting state fMRI. ROI-to-ROI analysis was performed.
RESULTS
In comparison to the LSP, the HSP had stronger interhemispheric connectivity of the amygdala (p = 0.01) and between the amygdala and nucleus accumbens (NAc) (p = 0.01). Amygdala connectivity was associated with higher pain catastrophizing in the HSP only (p<0.01).
CONCLUSIONS
These findings suggest that high sensitivity to pain may be reflected by neural circuits involved in affective and motivational aspects of pain. To what extent this connectivity within limbic brain structures relates to higher alertness and more profound withdrawal behavior to aversive events needs to be further investigated.
Identifiants
pubmed: 35442971
doi: 10.1371/journal.pone.0267170
pii: PONE-D-21-40586
pmc: PMC9020745
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0267170Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):355-60
pubmed: 19948949
Brain. 2016 Jul;139(Pt 7):1958-70
pubmed: 27190016
Brain Connect. 2017 Apr;7(3):182-196
pubmed: 28142257
Pain. 2016 Jun;157(6):1194-1198
pubmed: 26797678
J Mol Psychiatry. 2013 Jun 05;1(1):9
pubmed: 25408902
Neurosci Lett. 2019 May 29;702:15-23
pubmed: 30503916
Eur J Pain. 2004 Feb;8(1):31-8
pubmed: 14690672
Neurophysiol Clin. 2007 Aug-Sep;37(4):249-59
pubmed: 17996813
Behav Res Ther. 1983;21(4):401-8
pubmed: 6626110
Neurosci Lett. 2005 Jun 3;380(3):209-13
pubmed: 15862887
Pain. 2014 Aug;155(8):1659-1666
pubmed: 24861580
Pain. 2017 Feb;158(2):212-219
pubmed: 28092323
Nat Neurosci. 2012 Jul 01;15(8):1117-9
pubmed: 22751038
Hum Brain Mapp. 2013 Jan;34(1):109-49
pubmed: 22131304
Nat Neurosci. 2014 Oct;17(10):1304-12
pubmed: 25254980
Cell Mol Neurobiol. 2003 Oct;23(4-5):727-38
pubmed: 14514027
Pain. 2013 Sep;154(9):1792-1797
pubmed: 23714266
Psychopharmacology (Berl). 2007 Apr;191(3):521-50
pubmed: 16983543
Mol Psychiatry. 2001 Jan;6(1):13-34
pubmed: 11244481
Nat Rev Neurosci. 2004 Nov;5(11):844-52
pubmed: 15496862
Neuroreport. 2019 Mar 20;30(5):363-368
pubmed: 30762615
Eur J Pain. 2002;6(6):475-84
pubmed: 12413436
Pain. 1989 May;37(2):143-160
pubmed: 2664663
Eur J Pain. 2020 Mar;24(3):580-592
pubmed: 31770471
Neuropsychopharmacology. 1996 Sep;15(3):252-62
pubmed: 8873108
Clin J Pain. 2005 Sep-Oct;21(5):439-45
pubmed: 16093750
Neuroimage. 2019 Nov 15;202:116049
pubmed: 31349067
Curr Opin Neurobiol. 2008 Aug;18(4):464-8
pubmed: 18835354
Pain. 2016 Sep;157(9):1970-1978
pubmed: 27168362
Front Hum Neurosci. 2013 Oct 04;7:623
pubmed: 24109446
Pain Pract. 2014 Mar;14(3):E126-35
pubmed: 24256148
Neuroimage. 2013 Jul 15;75:68-78
pubmed: 23485593
Mol Neurobiol. 2019 Feb;56(2):1137-1166
pubmed: 29876878
Clin J Pain. 2001 Mar;17(1):52-64
pubmed: 11289089
Brain Connect. 2012;2(3):125-41
pubmed: 22642651
Neuroscientist. 2004 Jun;10(3):221-34
pubmed: 15155061
Neuroimage. 2005 Jan 1;24(1):235-43
pubmed: 15588615
Mol Brain. 2015 Mar 27;8:22
pubmed: 25888401
Prog Neurobiol. 2021 Jan;196:101891
pubmed: 32730859
Neuroimage. 2020 Nov 1;221:117164
pubmed: 32679253
J Cogn Neurosci. 2012 Jan;24(1):148-58
pubmed: 21861676
Neuron. 2008 Aug 28;59(4):648-61
pubmed: 18760700
J Neurosci. 2004 Mar 24;24(12):2923-33
pubmed: 15044531
Curr Opin Psychiatry. 2012 Mar;25(2):109-13
pubmed: 22227632
Eur J Pain. 2005 Aug;9(4):463-84
pubmed: 15979027
Brain. 2013 Sep;136(Pt 9):2751-68
pubmed: 23983029
Nat Commun. 2017 Feb 14;8:14211
pubmed: 28195170
Cogn Affect Behav Neurosci. 2013 Sep;13(3):501-18
pubmed: 23645370
Neural Regen Res. 2020 Apr;15(4):597-605
pubmed: 31638081
Prog Neurobiol. 2009 Feb;87(2):81-97
pubmed: 18952143
Brain. 2002 Jun;125(Pt 6):1326-36
pubmed: 12023321
Eur J Pain. 2010 Jul;14(6):608-14
pubmed: 19906552
Hum Brain Mapp. 2014 Feb;35(2):527-38
pubmed: 23097300
Nat Commun. 2020 Jan 10;11(1):187
pubmed: 31924769
Front Neurosci. 2013 Apr 02;7:46
pubmed: 23565073
PLoS One. 2019 Aug 12;14(8):e0221023
pubmed: 31404104
J Neurosci. 2004 Aug 11;24(32):7199-203
pubmed: 15306654
AJNR Am J Neuroradiol. 2016 Jun;37(6):1139-45
pubmed: 26767708
Pain Res Manag. 2002 Spring;7(1):21-30
pubmed: 16231064
Pain Rep. 2018 Oct 22;3(6):e694
pubmed: 30706037
Phys Ther. 2015 Nov;95(11):1536-46
pubmed: 26023218
Handb Exp Pharmacol. 2015;227:261-84
pubmed: 25846623
Neuroimage. 2008 Aug 15;42(2):717-25
pubmed: 18572418
Cereb Cortex. 2020 May 14;30(5):3116-3129
pubmed: 31838504
Eur J Neurosci. 2016 Feb;43(4):486-93
pubmed: 26547276
Cereb Cortex. 2016 Aug;26(8):3508-26
pubmed: 27230218
Neuroimage. 2009 Mar 1;45(1):169-80
pubmed: 19027077
J Pain. 2001 Jun;2(3):160-70
pubmed: 14622826
Pain. 2002 Sep;99(1-2):313-21
pubmed: 12237210
Cereb Cortex. 2009 Oct;19(10):2209-29
pubmed: 19221144
Br J Clin Psychol. 2005 Jun;44(Pt 2):227-39
pubmed: 16004657
Neuron. 2007 Sep 20;55(6):970-84
pubmed: 17880899